MolNFT v1 · #95825 · protein
X-ray structure of the cytochrome C-554 from chlorobaculum tepidum
4J20 · Cytochrome C-555: “X-ray structure of the cytochrome C-554 from chlorobaculum tepidum”. X-ray diffraction, 3 ligands (HEB, NA, SO4), 3 pockets (best druggability 0.71). MolNFT v1 #95825 on GenesisL1: 3D structure, binding sites and…
- PDB
- 4J20
- Type
- protein
- Length
- 176 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Cytochrome C-555
- UniProt
- Q8KG93
- Ligands
- HEB, NA, SO4
- Pockets
- 3 · best druggability 0.71
Structure
x-ray diffraction · 1 distinct chain · 60% helix, 5% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A, B | Cytochrome C-555 | protein | 88 | 60% helix, 5% strand | Q8KG93 |
Ligands and binding sites
- HEB · Heme B/C · ligand · 2 copies · chains A, B
- NA · Sodium ion · metal · chains A
- SO4 · Sulfate ion · ion · chains A
- IPA · Isopropyl alcohol · additive · 7 copies · chains A, B
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 153 | 0.71 | 0.90 | 35 | HEB |
| 2 | 160 | 0.68 | 0.87 | 34 | HEB |
| 3 | 117 | 0.42 | 0.76 | 25 | IPA |
Interfaces
1 interface between chains.
- A–B · 225 Ų buried · 1 hydrogen bond · protein-protein
Modifications
Observed in the structure: 4 covalent (covalent ligand).
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q8KG93
- Elsewhere: RCSB PDB 4J20 · PDBe 4J20 · UniProt Q8KG93
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.